As a consequence, BMDA or DMMA administration reduced expression levels of inflammatory cytokines such as IL-1β and TNF-α in LPS-stimulated THP-1 cells in vitro and in tissues from DNBS-induced colitis and collagen-induced arthritis in vivo. This evidence concerns the gene IL1B and colitis.